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Abstract
AIM
To investigate the prevalence and the risk of tempo-
romandibular disorders (TMDs) in patients with irritable 
bowel syndrome (IBS) (including each subtype: con-
stipation, diarrhoea, and mixed) compared to the 
general population.
METHODS
Between January 2014 and December 2015 we 
enrolled consecutively adult patients diagnosed with 
IBS at the outpatient clinic of the University of Salerno 
and healthy controls (HC) without IBS. At enrollment, 
we analyzed all patients for the presence of TMDs 
according to the Research Diagnostic Criteria for TMD.
RESULTS
We enrolled 91 IBS patients (23 IBS-D, 30 IBS-C and 
38 IBS-M) and 57 HC in the study. We found a higher 
risk of having TMD (OR = 3.41, 95%CI: 1.66-7.01) 
compared to the HC. The risk of having TMD was 
independent of IBS-subtype. Multiple regression 
analysis showed that facial pain was positively related 
to abdominal pain and higher level of depression.
CONCLUSION
IBS patients had a more than three times greater 
risk of TMD compared to HC. The risk of having TMD 
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was similar in different IBS subtypes. IBS patients 
that also fulfilled criteria for TMD seem to share along 
with chronic facial and abdominal pain a significant 
co-occurrence with psychiatric disorders and female 
preponderance.
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Core tip: Temporomandibular disorders (TMD) seem 
to occur more frequently in patients with irritable 
bowel syndrome (IBS). In this study we analyzed all 
patients for the presence of TMD according to the 
Research Diagnostic Criteria for Temporomandibular 
Disorders. Based on our results, IBS patients had a 
more than three times greater risk of TMD compared 
to healthy controls. The risk of having TMD was similar 
in different IBS subtypes. IBS patients that also fulfilled 
criteria for TMD seem to share along with chronic facial 
and abdominal pain a significant co-occurrence with 
psychiatric disorders and female preponderance.
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Irritable bowel syndrome (IBS) is a common chronic 
functional disorder of the lower gastrointestinal tract 
characterized by chronic pain or discomfort in the 
abdomen associated with altered bowel habits[1].  
Patients with IBS often complain of a variety of 
other GI (i.e., dyspepsia) and non-GI symptoms 
(i.e., migraine headaches, fatigue, sleep problems, 
dizziness, depression, anxiety, irritability, lower 
urinary tract symptoms and many IBS patients meet 
diagnostic criteria for other functional disorders[2], 
such as fibromyalgia (FM)[3], interstitial cystitis/
painful bladder syndrome (IC/PBS)[4], migraine[5], 
temporomandibular disorders (TMDs). However, the 
association between IBS and TMDs is still relatively 
unexplored[6,7].
TMDs are a heterogeneous group of diseases 
of the stomatognathic system that involve the 
temporomandibular joint (TMJ), masticatory muscles 
and their related structures[8]. The cardinal symptoms 
are pain in the TMJ and/or masticatory muscles, joint 
sounds and alterations in mandibular movement. 
The prevalence of TMD is recognized to be between 
5% to 12%[9] and this data has been confirmed also 
in an Italian population[10]. However, only 7% to 15% 
with TMDs, ask for medical help, mainly women of 
reproductive ages[11].
The classification of TMDs is controversial. A 
diagnostic model was proposed in 1992, known as the 
Research Diagnostic Criteria for Temporomandibular 
Disorders (RDC/TMD)[12]. Since its publication, the RDC/
TMD has been widely used in epidemiological, clinical 
and experimental studies[13]. Two diagnostic axes are 
contemplated: axis Ⅰ establishes a diagnosis based on 
clinical variables, while axis Ⅱ allows the assessment of 
mandibular function, psychological status and level of 
TMD-related psychosocial disability.
Previous cross-sectional research has suggested 
an association between TMD and IBS, however these 
studies have methodological limitations due to a self-
reported TMD diagnosis or old criteria to diagnose IBS 
as well as the small number of studied subjects[14-16].
In 2013 Sanders et al[17] showed that in a group of 
74 subjects with IBS symptoms the incidence of first 
onset of TMD was 3 times higher, compared to the 
group of 2632 subjects without IBS symptoms. In 2015 
another study showed that the number of comorbidities, 
IBS included, is positively associated with TMD pain 
duration and intensity, whereas among all comorbidities 
only the presence of specific conditions, such as 
migraine and chronic fatigue syndrome, is associated 
with an increase in TMD intensity and duration[5]. 
Interestingly, patients with IBS and another 
functional disorder, in comparison with patients with 
only IBS, have more severe IBS symptoms, a higher 
rate of psychological comorbidity such as depression, 
anxiety and somatization, greater impairment 
of quality of life, and more illness-related work 
absenteeism[18,19]. 
To our knowledge, the association between IBS and 
TMD taking into account the influence of IBS subtypes 
and illness severity has still not been sufficiently 
investigated. Increased awareness of the overlap 
between IBS and TMD likely will result in improved 
diagnoses and more effective management of both 
diseases[20]. Patients with IBS symptoms often are 
treated within a narrow gastrointestinal paradigm while 
clinicians ignore coexisting pain conditions, resulting in 
treatment failure and perpetuation of the problem.
The aims of the study were to evaluate, firstly, the 
risk of TMD determined on the basis of the RDC/TMD 
in IBS patients diagnosed by the Rome Ⅲ criteria, 
secondly the possible association between TMD and 
IBS subtype or severity. Finally, we aimed to observe 
any association between facial pain and abdominal 
pain. 
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MATERIALS AND METHODS
IBS patients (aged 18-65 years) were consecutively 
recruited for this study from an outpatient clinic of 
the University of Salerno devoted only to functional 
bowel disorders and run weekly by gastroenterologists 
trained in the field of functional bowel disorders (FBD). 
All patients attending this clinic were referred from 
general practitioners and/or other gastrointestinal 
clinics. At the same time, a dentist V.B. observed all 
patients recruited to this study.
For the purposes of the study, we recruited also 
healthy controls (HC) among the patients’ friends and 
the hospital staff, if scoring negative for IBS and with 
regular bowel habit similar for age and gender to IBS 
patients. Enrolment was done between January 2014 
and December 2015. All subjects gave their written 
informed consent and the Ethical Committee of the 
University of Salerno approved the study protocol. 
The diagnosis of IBS was made based on the Rome 
Ⅲ criteria, together with the exclusion of any organic 
disease, with complete physical examination, blood 
tests, flexible sigmoidoscopy and additional tests 
when indicated. Four different patterns of IBS resulted 
from the predominant bowel symptom: (1) diarrhoea 
predominant (IBS-D); (2) constipation predominant 
(IBS-C); (3) mixed IBS (IBS-M); and (4) unsubtyped 
IBS[21]. The IBS severity score was obtained using 
the severity index (IBS-SSS)[22]. This is a validated 
scoring system using easily obtained variables: current 
abdominal pain by visual analog scale (VAS) of 0-100 
and frequency of abdominal pain; current abdominal 
distension by VAS of 0-100; the degree of satisfaction 
of evacuative behavior by VAS 0-100; the degree of 
IBS interference with normal work and social activities 
by VAS 0-100. IBS patients were then divided into 
three severity groups: mild (75 to 175), moderate 
(175-300), and severe (> 300).
According to the Italian version of the RDC/
TMD criteria (Available from: http://www.rdc-
tmdinternational.org. Accessed (1 December 2013) 
all subjects from the two groups were investigated 
for TMD. The following elements were considered in 
the assessment of TMD: each patient’s responses to 
the validated subjective-symptoms questionnaire, an 
interview that included the patient’s detailed medical 
history, and the results of a physical examination. 
The history questionnaire included questions about 
prior trauma to the head and neck, awareness of 
bruxism, various diurnal and nocturnal parafunctional 
habits, muscle fatigue, locking, clicking, or crepitation 
in the temporomandibular joint during mandibular 
function, impaired mandibular movement, pain 
during mandibular function or while at rest, and prior 
treatment for TMD. 
The clinical examination of RDC/TMD axis Ⅰ consisted 
of the evaluation of masticatory muscles (temporal, 
masseter, medial, and lateral pterygoid), the temporo-
mandibular joint, the range of mandibular movement 
in opening, lateral, and protrusive excursions, and 
temporomandibular joint sounds. Manual palpation 
has been reported as the technique most commonly 
used to assess muscle pain; thus the examination 
of masticatory muscles was performed via bilateral 
manual palpation. 
Instead, the RDC/TMD axis Ⅱ has permitted 
the severity of chronic pain to be rated by means of 
the Graded Chronic Pain Scale (GCPS). The GCPS 
comprises the assessment of seven items assessed: 
3 items assessing the intensity of pain on a 10 point 
scale, including the current pain; 3 items assessing 
the impact of pain on a 10 point scale; and one item 
regarding the number of days of inability due to facial 
pain. The scoring criteria are simple to use and allow 
the categorization of pain into five levels of pain–
related impairment (Table 1).
Furthermore, the RDC/TMD axis Ⅱ has dealt with 
the assessment of depression and somatization levels 
by means of the depression and somatization scales 
of the Symptom Checklist 90R (SCL-90R)[23]. A total 
of 31 items were included in the axis Ⅱ, belonging 
either to the Depression and Vegetative Symptom 
Scale or to the Somatization Scale[24]. The mean scale 
score is calculated by simply adding the scores of 
the single item together. This allows patients to be 
rated as having normal, moderate or severe levels 
of impairment regarding depression and nonspecific 
physical symptoms (Table 2).
Statistical analysis
Data are presented as mean ± SE, unless otherwise 
indicated. P < 0.05 was considered statistically 
significant. χ 2 test and analysis of variance (ANOVA) 
were used to compare categorical and continuous data, 
respectively. The risk in IBS patients of having TMD 
compared to HC was analysed using a binary logistic 
regression. We then performed a subgroup analysis 
to test the risk of having TMD according to each IBS 
subgroup (IBS-D, IBS-C and IBS-M) using univariate 
logistic models. Two multivariate linear regression 
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Table 1  Chronic pain grade classification
Grade 0
Low disability  No TMD pain in prior 6 mo
Grade Ⅰ 
Low intensity  Characteristic pain intensity < 50, and less than 3 
disability points
Grade Ⅱ 




Moderately limiting 3 to 4 disability points, regardless of characteristic 
pain intensity
Grade Ⅳ 
Severely limiting 5 to 6 disability points regardless of characteristic 
pain intensity
Gallotta S et al . Temporomandibular disorders in IBS
106 January 7, 2017|Volume 23|Issue 1|WJG|www.wjgnet.com
Relationship between TMD and the type and severity of 
IBS
The risk of having TMD was similar in all three IBS 
subtypes, around three times higher than HC [IBS-D 
vs HC OR = 3.05 (95%CI: 1.11-8.37), IBS-C vs HC 
= 3.66 (1.44-9.30), IBS-M vs HC 3.46 (1.44-8.25)]. 
The respective prevalence was IBS-D 52.2% - IBS-C 
56.7% - IBS-M 55.3%.
Looking at the severity of IBS, there was not a 
significant higher IBS-SSS score in IBS patients with 
or without TMD (281.2 ± 12.5 vs 261.7 ± 17.1, P = 
0.35).
There was a significant positive correlation between 
the severity of chronic pain rated by means of the 
GCPS and the IBS-SSS (R = 0.17, P = 0.04). When 
multiple linear regression analysis was performed 
the GCPS was significantly related only to gender 
independent of age, IBS subtypes and IBS-SSS and 
depression (Table 3). 
Multiple linear regression analysis showed that 
the current facial pain scoring from 0 to 10 was 
significantly related to the current abdominal pain (0-10 
VAS) and to higher level of depression independent of 
gender, age, IBS subtypes and IBS-SSS (Table 4).
DISCUSSION
Our results showed that IBS patients had a TMD risk 
more than three times greater than HC. This increased 
risk is independent of any specific IBS subtype. Facial 
pain was positively related to abdominal pain and 
higher level of depression.
Studies on the association between TMD and 
IBS are scarce. In 1998 Korszun et al[14] reported 
the presence of IBS in 46% of 39 patients who self-
reported TMD diagnosis. In 2000 Aaron et al[15] 
showed that IBS was present in 64% of 25 TMD 
patients, however diagnosis of IBS was made using 
the Manning criteria. In 2001, Jones et al[16] presented 
at DDW an abstract in which the presence of self-
reported TMD diagnosis was 16% in 270 patients with 
IBS. Recently, in 2013 Sanders et al[17] in the multi-site 
OPPERA project performed a continuing prospective 
cohort study purposefully designed to investigate the 
etiology of first-onset TMD and variation in its genetic, 
biological and psychosocial determinants. Applying a 
rigorous methodology together with the large size of 
the study they demonstrated that incidence of first 
onset TMD was 3 times higher in people with IBS on 
enrolment as in people without IBS. IBS predicted 
first-onset TMD after adjustment for demographic 
characteristics and pain disorders; however their 
effects were rendered statistically non significant in 
the presence of other overlapping conditions. In this 
study the assessment of irritable bowel syndrome 
(IBS) symptoms was based on Rome Ⅲ criteria using 
two questions (52 and 53) that asked about bowel 
movements and the experience of discomfort or pain 
analyses were performed to analyze the relationships 
between illness severity of TMD and IBS taking into 
account age, sex, IBS severity, IBS subtypes and 
depression. The SPSS for Windows version 12.0 
statistical package (SPSS, Chicago, Ill., United States) 
was used for the data analysis. 
RESULTS
IBS Patients
None of the eligible patients refused to participate in 
the study. We enrolled 91 consecutive IBS patients (71 
females, mean age 36.6 ± 1.4 years) and 57 healthy 
controls (HC) (37 females, mean age 34.2 ± 1.7 
years) in the study. Gender and age distribution were 
not significantly different among groups (χ 2 test, P = 
0.08 and Student t test, P = 0.3).
IBS patients were classified as follow: 23 (25.3%) 
as IBS-D, 30 (33.0%) as IBS-C and 38 (41.8%) as 
IBS-M. On the basis of IBS-SSS, in our IBS population 
we had 11(12.1%) mild IBS, 41 (45.1%) moderate 
and 39 (42.9%) severe IBS. The severity score was 
120.0 ± 7.0 in mild IBS patients, 247.9 ± 6.8 in 
moderate IBS patients, and 361.3 ± 6.9 in severe IBS 
patients. 
Risk of TMD in IBS compared to HC
According to the RDC/TMD classification criteria, 
the IBS group had a greater than three times risk 
of having TMD (OR = 3.41, 95%CI: 1.66-7.01), 
compared to HC. In fact, TMD was diagnosed in 50 
(54.9%) IBS patients and 15 (26.3%) HC (χ 2 test, P = 
0.001). 
IBS patients compared to HC had significantly more 
facial pain (37.4% vs 19.3%, P = 0.02), TMJ locking 
(13.2 vs 3.5, P = 0.05) and TMJ clicking (41.8 vs 17.5, 
P = 0.002). TMJ crepitation was higher although it 
does not reach statistical significance (20.9 vs 10.5, P 
= 0.10). 
From the RDC/TMD axis Ⅱ the severity of 
chronic pain rated by means of the GCPS in IBS was 
grade Ⅰ low intensity in 22.0%, grade Ⅱ in 12.1% 
and grade Ⅲ in 2.2%. IBS patients compared to HC 
had a significantly higher score of depression (0.95 ± 
0.6 vs 0.62 ± 0.7, P = 0.001), of nonspecific physical 
symptoms (including the painful symptoms) (1.28 
± 0.1 vs 0.6 ± 0.06, P < 0.001) and of nonspecific 
physical symptoms (excluding the painful symptoms) 
(1.1 ± 0.08 vs 0.5 ± 0.07, P < 0.001). 
Table 2  Depression and somatization classification
Classification Normal Moderate Severe
Depression < 0.535 da 0.535 a 1.105 > 1.105
Nonspecific physical symptoms 
(including the painful symptoms)
< 0.500 da 0.500 a 1.000 > 1.000
Nonspecific physical symptoms 
(excluding the painful symptoms)
< 0.428 da 0.428 a 0.857 > 0.857
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in the abdomen that lasted at least one day a week 
during the previous three weeks[17]. 
Compared to the previous literature, our study 
has taken into account several factors. Firstly, our 
population was enrolled in a tertiary outpatients clinic 
devoted only to functional bowel disorders and run 
weekly by gastroenterologists trained in the field 
of functional bowel disorders (FBD) together with a 
dentist. The presence of TMD in this population of 
patients with IBS and HC was evaluated according to 
the RDC/TMD criteria that are worldwide-accepted 
criteria for the diagnosis of these disorders. Therefore, 
our study results could be more generalizable for IBS 
patients seeking treatment. Secondly, to give strength 
to our study, the diagnosis of IBS and its different 
subtypes was based on a standardized questionnaire 
according to Rome Ⅲ criteria and not on the patients’ 
subjective evaluation of their bowel habits. Moreover, 
we took into account the severity of IBS demonstrating 
a weak but significant correlation between the chronic 
grade of TMD pain and IBS severity according to 
Francis et al[22]; however, in the regression analysis this 
correlation was lost taking into account other factors. 
In fact, women resulted significantly related to the 
chronic grade of TMD confirmed that gender is a risk 
factor in TMD[11]. Finally, facial pain that is common 
in patients with TMD is strongly and positively related 
to abdominal pain and higher level of depression. 
We inquired about current facial and abdominal pain 
to avoid a recall bias. Chronic abdominal pain is the 
predominant feature in IBS. In fact the newest Rome 
Ⅳ criteria published last May eliminated the term 
discomfort from the diagnostic criteria and focused 
only on recurrent abdominal pain[25].
Furthermore, psychological status has been 
assessed and controlled for all subjects using RDC/
TMD axis Ⅱ by means of the 31 items belonging either 
to the Depression and Vegetative Symptom Scale or to 
the Somatization Scale[24].
There are some limitations in this study. First, the 
small number of IBS patients could have affected 
our results especially in the analyses of the IBS-
SSS association with TMD. However, facial pain is 
significantly correlated to higher abdominal pain and 
depression. In 2011 the Rome foundation working 
team stated that the physiological factors contributing 
to severity have both visceral and central nervous 
system contributions. As severity increases, the central 
nervous system provides a greater contribution and 
this is manifest by its co-association with psychosocial 
distress and comorbidities that increased symptom 
reporting and maladaptive coping[26].
Moreover, based on the current design, we were 
unable to investigate on the pathophysiological link 
between IBS and TMD. For instance, patients with 
both IBS and TMD are not only more pain sensitive[27] 
but also demonstrate reduced pain inhibition, possibly 
because of dysfunction of endogenous pain inhibition 
Table 3  Multiple regression analysis; the Chronic Pain Grade scale by age, gender, depression, IBS-symptom severity scale and l i l  r r ssi  analysis; the chronic pain grade scale by age, gender, depression, irritable bowel syndrome- ymptom
severity scale and irritable bowel syndrome subtypes
 Unstandardized coefficients Standardized 
coefficients
t Significance 95%CI
β SE β Lower Upper
Constant -0.220 0.530 -0.414 0.680 -1.274 0.834
Age -0.007 0.007 -0.121 -1.124 0.264 -0.020 0.006
Gender  0.436 0.204  0.229  2.132 0.036  0.029 0.842
Depression  0.352 0.184  0.201  1.911 0.059 -0.014 0.718
IBS-SSS -0.034 0.124 -0.290 -0.274 0.785 -0.280 0.213
IBS subtypes  0.032 0.109  0.031  0.292 0.771 -0.185 0.249
Dependent variable: Chronic pain grade scale. 
Table 4  Multiple regression analysis; facial pain by age, gender, abdominal pain, depression, irritable bowel syndrome-symptom 
severity scale and irritable bowel syndrome subtypes
Unstandardized coefficients Standardized 
coefficients
t Significance 95%CI
β SE β Lower Upper
Costant -0.891 0.720  -1.239 0.217 -2.314 0.531
Age -0.001 0.012 -0.008 -0.104 0.917 -0.024 0.022
gender  0.292 0.338  0.071  0.866 0.388 -0.375 0.960
Abdominal pain VAS  0.220 0.083  0.396  2.644 0.009  0.056 0.384
IBS-SSS -0.485 0.274 -0.329 -1.770 0.079 -1.026 0.057
Depression classification  0.473 0.189  0.205  2.501 0.014  0.099 0.848
Subtypes di IBS e HC  0.204 0.200  0.130  1.019 0.310 -0.191 0.598
Dependent variable: facial pain VAS (0-10).
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systems in accordance with the theory of a genera-
lized upregulation of pain processing in chronic pain 
conditions[28].
This may predispose to the development of other 
chronic pain syndromes (i.e., IBS leading to TMD) 
or may lead to the transition from a localized pain 
disorder to a widespread pain disorder[29].
In addition, psychological symptoms were shown to 
contribute to these sensory dysfunctions and may be 
involved in pain modulation processes that are related 
to chronic pain. 
These findings could be clinically relevant, sug-
gesting that in order to improve IBS symptoms other 
existing comorbidities need to be assessed, probably 
in interdisciplinary clinics hosting multiple health 
professions. 
In addition, studies about the treatment of these 
co-morbid conditions have shown that a simultaneous 
therapeutic approach to multiple diseases is more 
effective than the separate treatment of each[20]. Thus 
a multidisciplinary therapy should be encouraged. 
Likewise, future research elucidating neurobehavioral 
processes underlining chronic pain is welcomed.
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